Kent Kiracofe, MD
Family Medicine · Manhattan, KSNPI 1285689380
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $179,196 of the $188,505 with a category attached, or 95.1%. 48 manufacturers reported payments, led by CSL Plasma Inc. at 49.0% of the total. Among family medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 846 payments — averaging $222.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$92K
- CSL Behring$87K
- Pfizer$1K
- AbbVie$1K
- Novo Nordisk$995
- AstraZeneca$908
- plus $5K from 42 others
What the payments were for
- Consulting fees$179,19695%
- Food & beverage$9,3095%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$188,505 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 60 | $65,562 |
| EliquisApixaban | 93 | $59,537 |
| TrulicityDulaglutide | 50 | $56,861 |
| OzempicSemaglutide | 28 | $26,193 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 28 | $20,756 |
| Xigduo XrDapaglifloz Propaned/Metformin | 37 | $19,150 |
| JardianceEmpagliflozin | 22 | $17,373 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $11,949 |
| XareltoRivaroxaban | 14 | $7,611 |
| FarxigaDapagliflozin Propanediol | 12 | $6,871 |
| GemtesaVibegron | 17 | $5,502 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 12 | $3,781 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 16 | $3,432 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $3,147 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $2,653 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $795 | $122,423110 claims |
| PfizerEliquis, Abrysvo | $1,362 | $63,317105 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance | $295 | $38,12950 claims |
| Novo NordiskOzempic | $995 | $26,19328 claims |
| GSKTrelegy Ellipta, Shingrix | $305 | $15,38129 claims |
| Johnson & JohnsonXarelto | $179 | $7,61114 claims |
| AstraZenecaFarxiga | $908 | $6,87112 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $68 | $5,50217 claims |
| AbbVieArmour Thyroid | $1,242 | $1,15612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Manhattan
- Bradley HarrisonManhattan$314K
- Kyle PlatzManhattan$51K
- Mila MeansWichita$241K
- Scott AveryJunction City$195K
- Terry McGeeneyLeawood$147K
- Cole GillenwaterWichita$62K
- David StricklandLawrence$53K
- Eric AspinwallKansas City$28K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.